Advanced search
Publication Cover
mAbs Volume 15, 2023 - Issue 1
Submit an article Journal homepage
4,929
Views
4
CrossRef citations to date
0
Altmetric
Report

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies

Andrew Dippelh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Austin Gallegosg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Vineela Aletih Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Arnita Barnesh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Xiaoru Chene Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Elizabeth Christiang Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Jared Delmarg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Qun Duh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Reza Esfandiaryg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Erika Farmerg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Andrew Garciah Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Qing Lid Hansoh Bio, Rockville, MD, USA;h Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Jia Linh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Weiyi Liuc Pfizer, La Jolla, CA, USA;e Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
LeeAnn Machieskyg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Neil Modyg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Arun Parupudig Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Meagan Prophetg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Keith Rickerth Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Kim Rosenthalf Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Song Rene Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Harini Shandilyah Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Reena Varkeyh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Kevin Wonsg Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Yuling Wue Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Yueh-Ming Loof Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Mark T. Esserf Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Nicole L. Kallewaardb Eli Lilly, Indianapolis, IN, USA;f Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Sarav Rajanh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Melissa Damschroderh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Weichen Xua Biopharmaceutical Development, MacroGenics, Rockville, MD, USA;g Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
View further author information
&
Gilad Kaplanh Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1374-305XView further author information
ORCID Icon show all
Article: 2152526 | Received 08 May 2022, Accepted 23 Nov 2022, Published online: 08 Dec 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.